Atlas Trials

The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations

Clinical trial NCT04363840 · WITHDRAWN

Trial details

NCT number
NCT04363840
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVIDVitamin D DeficiencyCoagulopathyDisseminated Intravascular Coagulation
Start date
2020-05-01
Primary completion
2020-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.